title: Guideline summary: appropriate use of tigecycline.
abstract: Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs).  This article serves as a summary of the guideline on the appropriate use of tigecycline, published in mid-2010 as a collaborative effort by representatives of the Association of Surgeons of South Africa, the Critical Care Society of Southern Africa, the Federation of Infectious Diseases Societies of Southern Africa, the South African Thoracic Society and the Trauma Society of South Africa.
authors.affiliation: Ampath National Laboratory Services, Milpark Hospital, Johannesburg. BrinkA@AMPATH.CO.ZA
authors.forename: A J
authors.initials: AJ
authors.lastname: Brink
authors.forename: D
authors.initials: D
authors.lastname: Bizos
authors.forename: K D
authors.initials: KD
authors.lastname: Boffard
authors.forename: C
authors.initials: C
authors.lastname: Feldman
authors.forename: D C
authors.initials: DC
authors.lastname: Grolman
authors.forename: J
authors.initials: J
authors.lastname: Pretorius
authors.forename: G A
authors.initials: GA
authors.lastname: Richards
authors.forename: E
authors.initials: E
authors.lastname: Steyn
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004358:Drug Therapy / Q000592:standards; D004359:Drug Therapy, Combination / Q000592:standards; D006801:Humans; D008911:Minocycline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D000078304:Tigecycline
chemical_list: D000900:Anti-Bacterial Agents; D000078304:Tigecycline; D008911:Minocycline